Join Covington for a webinar discussion of pharmaceutical and medical device patent litigation trends as part of our Life Sciences Essentials Series.

Topics will include a discussion of Section 337 patent litigation at the ITC, the growing wave of Patent Office challenges to pharma patents, increasing inter partes review and other challenges, and trends in “reverse payment” antitrust litigation in the wake of FTC v. Actavis.

Panelists and Topics:

• Shara Aranoff – Current trends in Section 337 patent litigation at the ITC, including the evolving domestic industry requirement and the heightened focus on public interest and enforcement issues.

• Andrea Reister – The growing wave of Patent Office challenges to pharma patents, the impending tsunami of inter partes review and other challenges from generic applicants, hedge funds, and competitors in the pharmaceutical industry.

• Andrew Lazerow – Current trends in “reverse payment” antitrust litigation in the wake of FTC v. Actavis, the Supreme Court’s only decision in this area of the law standing at the intersection of antitrust law and patent law.